We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Plastic Antibodies Prevent Poisoning in Mouse Model

By LabMedica International staff writers
Posted on 23 Jun 2010
Synthetic plastic nanoparticles have been shown capable of acting like antibodies to selectively attach and remove a toxic substance from the blood of laboratory mice.

Investigators at the University of California, Irvine (USA) in collaboration with colleagues from the University of Shizuoka (Japan) created plastic analogs of an antibody that recognized the poison melittin. More...
Melittin, a peptide of 26 amino acids, is one of the toxic peptides in bee venom.

The artificial antibodies were produced by incubating melittin together with plastic monomers. A chemical reaction was started that allowed the plastic to polymerize around the molecules of melittin, which were then leached out of the matrix. The result was nanoparticles with cavities that matched the structure of melittin.

The investigators reported in the April 26, 2010, online edition of the Journal of the American Chemical Society (JACS) that treating mice that had been injected with a lethal dose of melittin with the synthetic antibodies significantly diminished the mortality and peripheral toxic symptoms of the melittin. In vivo imaging confirmed that the polymer plastic antibodies accelerated clearance of the peptide from the blood and accumulated in the liver.

Commenting on the significance of the results, senior author Dr. Kenneth Shea, professor of medical biochemistry at the University of California, Irvine, said, "This opens the door to serious consideration for these nanoparticles in all applications where antibodies are used.”

Related Links:
University of California, Irvine
University of Shizuoka



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.